CKD anemia market expected to reach $5.3bn across the 7MM by 2034
The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) of 1.7% from $4.4bn in 2024 to $5.3bn in 2034, according to leading data and analytics company GlobalData’s recently published report, Chronic Kidney Disease Anemia: Opportunity Assessment and Forecast.
The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) of 1.7% from $4.4bn in 2024 to $5.3bn in 2034, according to leading data and analytics company GlobalData’s recently published report, Chronic Kidney Disease Anemia: Opportunity Assessment and Forecast.
What's Your Reaction?
